Abstract
Background
Lipopolysaccharide-binding protein (LBP) is a class 1 acute-phase protein that binds and transfers bacterial lipopolysaccharide (LPS). This study investigated the clinical value of measuring LBP for stratifying biochemical severity in acute pancreatitis by using a recently developed fully automated assay technique.
Patients and methods
We studied 71 patients with acute pancreatitis of whom 41 presented with a necrotizing course. Necrotizing pancreatitis was associated with pancreatic infections in 21 patients and with multiorgan dysfunction syndrome (MODS) in 18 patients. Serum LBP was measured for 14 days by a fully automated immunoassay and CRP was assessed on a daily routine basis.
Results
The relative quantitative systemic release of LBP was lower than that observed for CRP; however, the two parameters revealed similar dynamics, with a maximum increase in acute pancreatitis around the fourth day after onset of symptoms. As observed for CRP, LBP was significantly higher in patients who developed complications such as necrosis, pancreatic infections, single or combined MODS than in those who did not. Multiple regression analysis revealed that pulmonary failure and MODS were independent variables associated with enhanced LBP release, while the development of necrosis, pancreatic infections and MODS were the corresponding variables for increased CRP levels.
Conclusions
Systemic LBP concentrations are significantly elevated in acute pancreatitis and closely correlate with overall disease severity. However, compared with CRP, LBP does not contribute to an improved severity stratification in acute pancreatitis.
Similar content being viewed by others
References
Beger HG, Bittner R, Block S, Büchler M (1986) Bacterial contamination of pancreatic necrosis. Gastroenterology 49:433–438
Isenmann R, Rau B, Beger HG (1999) Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 86:1020–1024
Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, Banks PA (1997) Relationship of necrosis to organ failure in sever acute pancreatitis. Gastroenterology 113:899–903
Banerjee AK, Kaul A, Bache E, Doran J, Nicholson ML (1994) Multicentre audit of death from acute pancreatitis. Br J Surg 81:1541
Schulz HU, Niederau C, Klonowski-Stumpe H, Halangk W, Luthen R, Lippert H (1999) Oxidative stress in acute pancreatitis. Hepatogastroenterology 46:2736–2750
Norman J (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 175:76–83
Saluja AK, Steer ML (1999) Pathophysiology of acute pancreatitis. Role of cytokines and other mediators of inflammation. Digestion 60:127–133
Buttenschoen K, Berger D, Hiki N, Buttenschoen DC, Vasilescu C, Chikh-Torab F, Seidelmann M, Beger HG (2000) Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis. Eur J Surg 166:459–466
Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, DiPadova F, et al (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217–225
Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide binding protein. Science 249:1429–1431
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433
Schumann RR (1992) Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol 143:11–15
Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ (1992) Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of Gram-negative LPS. J Immunol 149:200–206
Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD (1994) Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as cofactor in the neutralization of LPS. J Exp Med 180:1025–1035
Froon A, AHM, Dentener MA, Greve JWM, Ramsay G, Buurman WA (1995) Lipopolysaccharide toxicity–regulating proteins in bacteremia. J Infect Dis 171:1250–1257
Myc A, Buck J, Gonin J, Reynolds B, Hammerling U, Emanuel D (1997) The level of lipopolysacchride-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol 4:113–116
Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584–1589
Erwin PJ, Lewis H, Dolan S, Tobias PS, Schumann RR, Lamping N, Wisdom GB, Rowlands BJ, Halliday I (2000) Lipopolysaccharide binding protein in acute pancreatitis. Crit Care Med 28:104–109
Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I (1999) Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 25:195–210
Buchler MW, Gloor B, Muller CA, Friess H, Seiler CA, Uhl W (2000) Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 232:619–626
Schoonjans F, Zalata A, Depuydt CE, Comhaire FH (1995) MedCalc: a new computer program for medical statistics. Comp Methods Prog Biomed 48:257–262
Runkel N (1998) Pathogenesis of pancreatogenic sepsis. Langenbecks Arch Chir Suppl Kongressbd 115:439–442
Novitsky TJ (1994) Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. J Endotoxin Res 1:253–263
Rolansky PE, Novitsky TJ (1991) Sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans. J Clin Microbiol 29:2477–2483
Schumann RR, Zweiger J (1999) A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 37:271–274
Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhardt K (1998) Procalcitonin. Ein neuer diagnostischer Parameter bei schweren Infektionen und Sepsis. Anaesthesist 47:581–587
Russwurm S, Oberhoffer M, Zipfel PF, Reinhardt K (1999) Procalcitonin-a novel biochemical marker for the mediator directed therapy of sepsis. Mol Med Today 5:286–287
Rau B, Steinbach G, Gansauge F, Mayer JM, Grünert A, Beger HG (1997) The potential role of procalcitonin and interleukin-8 in the prediction of infected necrosis in acute pancreatitis. Gut 41:832–840
Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG (2000) Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med 28:736–742
Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG (1991) PMN-Elastase in comparison with CRP, antiproteases and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 6:253–259
Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA (2000) Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 355:1955–1960
Mayer J, Rau B, Grewe M, Schoenberg MH, Nevalainen T, Beger HG (1998) Secretory Phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas 17:272–277
Acknowledgements
We thank DPC Biermann, Bad Nauheim, Germany for their support by kindly providing the LBP kits.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rau, B., Steinbach, G., Krüger, C.M. et al. Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis. Langenbecks Arch Surg 388, 181–188 (2003). https://doi.org/10.1007/s00423-003-0390-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-003-0390-6